BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25623532)

  • 21. Tivantinib in hepatocellular carcinoma.
    Trojan J; Zeuzem S
    Expert Opin Investig Drugs; 2013 Jan; 22(1):141-7. PubMed ID: 23167786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
    Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
    Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown.
    Previdi S; Abbadessa G; Dalò F; France DS; Broggini M
    Mol Cancer Ther; 2012 Jan; 11(1):214-23. PubMed ID: 22027690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
    Gao L; Dong J; Zhang N; Le Z; Ren W; Li S; Li F; Song J; Wang Q; Dou Z; Park SY; Zhi K
    Anticancer Agents Med Chem; 2019; 19(2):248-255. PubMed ID: 30378503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition.
    Reuther C; Heinzle V; Spampatti M; Vlotides G; de Toni E; Spöttl G; Maurer J; Nölting S; Göke B; Auernhammer CJ
    Neuroendocrinology; 2016; 103(3-4):383-401. PubMed ID: 26338447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
    Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
    Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia.
    Kuenzi BM; Remsing Rix LL; Kinose F; Kroeger JL; Lancet JE; Padron E; Rix U
    Sci Rep; 2019 Jan; 9(1):606. PubMed ID: 30679640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
    Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
    Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dietary phytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, and p53 signaling.
    Weng JR; Bai LY; Chiu CF; Wang YC; Tsai MH
    Chem Biol Interact; 2012 Feb; 195(3):224-30. PubMed ID: 22290291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tivantinib (ARQ197) in hepatocellular carcinoma.
    Porta C; Giglione P; Ferrari A; Reversi F; Liguigli W; Imarisio I; Ganini C
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):615-22. PubMed ID: 26035719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural diterpenoid ovatodiolide induces cell cycle arrest and apoptosis in human oral squamous cell carcinoma Ca9-22 cells.
    Hou YY; Wu ML; Hwang YC; Chang FR; Wu YC; Wu CC
    Life Sci; 2009 Jul; 85(1-2):26-32. PubMed ID: 19409917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells.
    Tsai SC; Lu CC; Lee CY; Lin YC; Chung JG; Kuo SC; Amagaya S; Chen FN; Chen MY; Chan SF; Yang JS
    Int J Oncol; 2012 Nov; 41(5):1683-92. PubMed ID: 22922805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis.
    Chien MH; Lee TS; Kao C; Yang SF; Lee WS
    Mol Carcinog; 2012 May; 51(5):389-99. PubMed ID: 21563217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway.
    Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR
    Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancer.
    Tolaney SM; Tan S; Guo H; Barry W; Van Allen E; Wagle N; Brock J; Larrabee K; Paweletz C; Ivanova E; Janne P; Overmoyer B; Wright JJ; Shapiro GI; Winer EP; Krop IE
    Invest New Drugs; 2015 Oct; 33(5):1108-14. PubMed ID: 26123926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naphtho[1,2-b]furan-4,5-dione induces apoptosis of oral squamous cell carcinoma: involvement of EGF receptor/PI3K/Akt signaling pathway.
    Chien CM; Lin KL; Su JC; Chuang PW; Tseng CH; Chen YL; Chang LS; Lin SR
    Eur J Pharmacol; 2010 Jun; 636(1-3):52-8. PubMed ID: 20371243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-cancer properties of glucosamine-hydrochloride in YD-8 human oral cancer cells: Induction of the caspase-dependent apoptosis and down-regulation of HIF-1α.
    Jung CW; Jo JR; Lee SH; Park YK; Jung NK; Song DK; Bae J; Nam KY; Ha JS; Park IS; Park GY; Jang BC; Park JW
    Toxicol In Vitro; 2012 Feb; 26(1):42-50. PubMed ID: 22020377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HDAC inhibitor, panobinostat, induces apoptosis by suppressing the expresssion of specificity protein 1 in oral squamous cell carcinoma.
    Jeon YJ; Ko SM; Cho JH; Chae JI; Shim JH
    Int J Mol Med; 2013 Oct; 32(4):860-6. PubMed ID: 23877235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.
    Okamoto A; Higo M; Shiiba M; Nakashima D; Koyama T; Miyamoto I; Kasama H; Kasamatsu A; Ogawara K; Yokoe H; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(11):e0142252. PubMed ID: 26554377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piperlongumine Suppresses Proliferation of Human Oral Squamous Cell Carcinoma through Cell Cycle Arrest, Apoptosis and Senescence.
    Chen SY; Liu GH; Chao WY; Shi CS; Lin CY; Lim YP; Lu CH; Lai PY; Chen HR; Lee YR
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27120594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.